Johnson & Johnson And AbbVie: 2 Great Dividend Aristocrats For What's Coming NextSeeking Alpha • 08/04/22
Medicare Drug Pricing Changes Could Be Coming: Time to Ditch Pharma Stocks?The Motley Fool • 08/03/22
Sosei Heptares and AbbVie Enter New Multi-target Collaboration to Discover, Develop and Commercialize Novel Medicines Targeting Neurological DiseasesGlobeNewsWire • 08/01/22
ABBVIE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of AbbVie Inc. - ABBVPRNewsWire • 07/30/22
AbbVie Inc. (ABBV) CEO Rick Gonzalez on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 07/29/22